Enzon To Restate Financial Statements From Late 2003 Through 2005
This article was originally published in The Pink Sheet Daily
The company has postponed its fourth quarter earnings report, originally scheduled for release Aug. 17.
You may also be interested in...
Dr. Reddy's, GSK, Ranbaxy and UCB among manufacturers that could see prices reduced under government order that reflects issues raised in Gleevec patent dispute.
Indian regulators threaten compulsory licensing of the oncologic, but Novartis says it has no plans to end its bid for patent protection.
Patent case for new form of imatinib will now be reviewed by newly formed Intellectual Property Appellate Board.